Recent HROW News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/11/2026 06:50:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 12:26:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:05:14 PM
- Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference • GlobeNewswire Inc. • 03/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:05:17 PM
- Harrow Wins FDA Clearance to Launch Phase 3 Trial Aimed at Expanding TRIESENCE Label in Cataract Surgery • IH Market News • 03/03/2026 03:39:49 PM
- Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 09:31:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 09:15:59 PM
- Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance • GlobeNewswire Inc. • 03/02/2026 09:05:00 PM
- Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 • GlobeNewswire Inc. • 02/18/2026 12:00:00 PM
- Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits • GlobeNewswire Inc. • 02/17/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 01:21:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 12:30:56 PM
- Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth • GlobeNewswire Inc. • 02/02/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2026 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 01:50:10 AM
- Harrow to Present at Two Investor Conferences in December • GlobeNewswire Inc. • 11/24/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 01:00:40 PM
- Harrow Announces Closing of Acquisition of Melt Pharmaceuticals • GlobeNewswire Inc. • 11/18/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 10:16:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 10:09:05 PM
- Harrow Announces Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/10/2025 09:05:00 PM
- Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 • GlobeNewswire Inc. • 10/27/2025 11:00:00 AM
- ImprimisRx Announces Leadership Changes • GlobeNewswire Inc. • 10/06/2025 11:00:00 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
